OGN
Organon·NYSE
--
--(--)
--
--(--)
OGN fundamentals
Organon (OGN) Revenue Breakdown: Q4 2025 Business & Regional Performance
Organon (OGN) reported total revenue of 1.51B USD in Q4 2025, with its core business segment Women’s Health contributing 26.41%. Regionally, Europe and Canada remained the largest market, accounting for 26.87% of total revenue. Explore Organon's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Organon (OGN) reported total revenue of 1.51B USD in Q4 2025, with its core business segment Women’s Health contributing 26.41%. Regionally, Europe and Canada remained the largest market, accounting for 26.87% of total revenue. Explore Organon's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What were the key takeaways from Organon’s earnings call?What is Organon's gross profit margin?What is Organon's latest dividend and current dividend yield?Did Organon beat or miss consensus estimates last quarter?What guidance did Organon's management provide for the next earnings period?What factors drove the changes in Organon's revenue and profit?What were the key takeaways from Organon's earnings call?What is the market's earnings forecast for Organon next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
